Table 22: Dataset - grade complete

Completeness of the dataset (%) - grade complete by cancer site groups summary (persons)
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 60.0% 60.9% 59.9% 59.7% 63.0% 60.9%
All xnmsc 0-24 28.4% 32.2% 27.4% 36.3% 41.9% 23.2%
All xnmsc 25-59 67.2% 69.2% 66.8% 69.0% 71.4% 69.7%
All xnmsc 60-79 64.8% 65.6% 64.7% 64.0% 67.8% 65.7%
All xnmsc 80+ 41.5% 40.6% 41.8% 38.1% 40.8% 41.6%
All registrations 44.5% 42.8% 44.7% 45.8% 36.8% 44.0%
Haematology 15.3% 31.1% 12.2% 33.9% 70.4% 7.7%
Head and Neck 78.3% 82.2% 77.2% 80.0% 86.1% 85.6%
Lower GI 78.8% 77.6% 79.0% 78.4% 74.8% 78.1%
Upper GI 77.0% 76.3% 77.3% 75.6% 77.4% 75.0%
HPB 29.7% 26.2% 30.8% 22.6% 25.1% 26.2%
Trachea, Bronchus & Lung 26.8% 27.9% 26.4% 27.4% 25.9% 32.1%
Melanoma of skin 0.8% 0.3% 0.9% 0.1% 0.0% 0.3%
Breast 96.5% 96.1% 96.6% 95.8% 95.8% 96.2%
Cervix 82.6% 80.8% 82.2% 89.6% 67.0% 84.6%
Other Female Genitals 76.3% 77.2% 76.1% 75.6% 79.2% 77.8%
Prostate 83.6% 83.2% 83.6% 82.0% 80.7% 86.6%
Kidney 58.4% 57.1% 58.7% 57.6% 56.8% 55.3%
Bladder 84.3% 86.3% 83.9% 85.7% 88.5% 87.2%
Brain and CNS 68.1% 62.7% 69.4% 65.0% 61.6% 54.9%
Thyroid and other endocrine glands 18.4% 13.3% 19.5% 11.3% 1.6% 20.9%
CUP 21.6% 18.6% 22.4% 17.5% 14.9% 19.8%
Other invasive cancer 30.3% 30.2% 30.5% 27.3% 30.8% 32.4%
Other tumours 86.4% 24.4% 36.2% 17.1% 11.3% 33.0%
Non-Melanoma Skin Cancer 1.9% 23.8% 28.5% 32.6% 9.4% 24.6%